Zurich, July 26 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Friday:
COMPANY STATEMENTS
* Galenica said Injectafer received US FDA approval for the treatment of iron deficiency anaemia.
* Panalpina said it improved profitability in the second quarter.
* Swissquote said it was expecting to see net new money of about 1 billion Swiss francs in 2013 after assets under managemenet climbed 13.6 percent in the first half.
* ABB said it completed the acquisition of Power-One.
* Meyer Burger awarded two contracts totalling over CHF 5 million with customers in Asia and Europe.
* Interroll said it was expecting higher operating and net profit for the first half year 2013.
* Starrag Group Holding AG published its half year 2013 earnings release
* Graubuendner Kantonalbank said first-half group profit rose 2.3 percent to 88.1 million Swiss francs.
* Autoneum Holding AG half year 2013 earnings release
* Bellevue Group AG published its half year 2013 earnings release.
* Calida Holding AG said it posted profitable growth in the first half of 2013.
ECONOMY